HFA Premium Access

Effects of serelaxin on a systolic cardiac dysfunction induced by isoproterenol in mice with increased cardiac aldosterone

Topic: Animal models and experimentation

Congress Presentation

About the speaker

Doctor Gilles Billebeau

Hospital Lariboisiere, Paris (France)
0 follower

5 more presentations in this session

Novel drugs in heart failure: what's on the horizon?

Speaker: Professor C. Maack (Wuerzburg, DE)


Why treatment with natriuretic peptide analogs failed to fulfill our expectations? - receptor expression and function in a failing heart.

Speaker: Doctor K. Kodziszewska (Warsaw, PL)


ORM-3819 promotes cardiac contractility on a dual mechanism of action: troponin-C dependent calcium sensitization is supported by selective PDE III inhibition

Speaker: Doctor L. Nagy (Debrecen, HU)


Vepoloxamer (purified poloxamer-188) improves LV function, limits cardiomyocyte calcium overload and restores integrity of calciu cycling proteins in myocardium of dogs with advanced heart failure

Speaker: Professor H. Sabbah (Detroit, US)


Targeting HDACs in heart failure.


Access the full session

Novel drugs - how do they work?

Speakers: Doctor G. Billebeau, Professor C. Maack, Doctor K. Kodziszewska, Doctor L. Nagy, Professor H. Sabbah

About the event



21 May - 24 May 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb